FDA 483 - Kolmar Korea Co., Ltd. - Gwanjeong Factory - February 16, 2024
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Kolmar Korea Co., Ltd. - Gwanjeong Factory in Chungcheongnam-Do, Korea, received a Form FDA 483 with six observations during an inspection from February 8-16, 2024. The inspection revealed significant deficiencies in quality control, batch record documentation, data integrity, product traceability, and raw material warehousing for OTC drug products shipped to the US market. These issues indicate a lack of robust quality systems and adherence to good manufacturing practices.
- Office
- Office of Partnerships
- Person
ID · e92f5c2e-df6a-4051-a103-7b8421a73131